Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

Simple blood test may soon help detect colon cancer OncoRedox’s AI-powered sensor analyzes plasma samples and identifies molecules associated with cancer.

The FDA-approved Shield Blood Test, available for patients age 45 and up, is seen as a good first step for patients who may be apprehensive about getting a colonoscopy, or in places where ...

Companies claim that some screenings can identify dozens of cancers from a simple blood test. Here's what they can and can't ...

Created by Guardant Health, the blood test, known as Shield, was able to detect 83% of colorectal cancers in studies but only 13% of dangerous polyps. Colonoscopies find approximately 95% of these ...

For adults with average cancer risk, a blood test could provide an option for colon cancer screening instead of a colonoscopy. The Food and Drug Administration has approved a blood test, Shield ...

The FDA approved a new blood-based method of colon cancer detection this week — offering a new alternative to catch more cases of a leading cause of cancer deaths, but one some physicians ...

The Food and Drug Administration (FDA) announced that they have approved a new blood test for colorectal cancer (CRC).

It is the first blood test approved by the FDA as a primary screening option for the cancer and the first blood test of its kind to meet the requirements for Medicare coverage.